Celldex Therapeutics CLDX

$ 26.28 -0.45%

Quarterly report 2024-Q3
added 11-06-2024

Celldex Therapeutics Balance Sheet 2011-2024 | CLDX

Annual Balance Sheet Celldex Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-32.3 M	-25.4 M	-36.1 M	-	-7.58 M	-19.8 M	-33.7 M	-42.5 M	-67.7 M	-25.4 M	-169 M	-13.6 M	3.46 M
Long Term Debt	928 K	2.59 M	1.3 M	-	-	-	-	-	-	-	-	5.75 M	9.01 M
Long Term Debt Current	1.61 M	1.44 M	1.75 M	1.33 M	1.94 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	17.3 M	19.1 M	51.5 M	82.7 M	17.2 M	11.9 M	6.95 M	12.1 M	15 M
Total Current Liabilities	31.1 M	18.6 M	16.5 M	14.2 M	11.6 M	12.6 M	27.7 M	35.2 M	30.2 M	24.5 M	20.4 M	17.7 M	14.3 M
Total Liabilities	36.5 M	26.5 M	25.2 M	26.5 M	28.9 M	31.7 M	79.3 M	118 M	47.5 M	36.4 M	27.3 M	29.8 M	29.3 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.4 B	-1.26 B	-1.14 B	-1.07 B	-1.01 B	-962 M	-813 M	-719 M	-591 M	-464 M	-346 M	-264 M	-205 M
Total Assets	466 M	353 M	445 M	236 M	123 M	156 M	316 M	383 M	338 M	248 M	347 M	126 M	98 M
Cash and Cash Equivalents	34.8 M	29.4 M	39.1 M	43.8 M	11.2 M	24.3 M	40.3 M	42.5 M	72.1 M	28 M	169 M	24.9 M	11.9 M
Book Value	429 M	326 M	419 M	209 M	94 M	124 M	236 M	265 M	290 M	212 M	320 M	95.8 M	68.7 M
Total Shareholders Equity	429 M	326 M	419 M	209 M	94 M	124 M	236 M	265 M	290 M	212 M	320 M	95.8 M	68.7 M

All numbers in USD currency

Quarterly Balance Sheet Celldex Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	1.71 M	796 K	470 K	928 K	1.3 M	1.72 M	2.16 M	2.59 M	2.19 M	2.59 M	841 K	1.3 M	1.71 M	1.45 M	1.76 M	2.15 M	2.15 M	2.15 M	2.15 M	1.71 M	1.71 M	1.71 M	1.71 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	37.3 M	31.9 M	30.2 M	36.5 M	33.5 M	21.8 M	21.8 M	26.5 M	23.8 M	37.9 M	25.9 M	25.2 M	23.5 M	22.3 M	24.9 M	26.5 M	26.5 M	26.5 M	26.5 M	28.9 M	28.9 M	28.9 M	28.9 M	31.7 M	31.7 M	31.7 M	31.7 M	79.3 M	79.3 M	79.3 M	79.3 M	118 M	118 M	118 M	118 M	47.5 M	47.5 M	47.5 M	47.5 M	36.4 M	36.4 M	36.4 M	36.4 M	27.3 M	27.3 M	27.3 M	27.3 M	29.8 M	29.8 M	29.8 M	29.8 M	29.3 M	29.3 M	29.3 M	29.3 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.51 B	-1.47 B	-1.43 B	-1.4 B	-1.35 B	-1.32 B	-1.29 B	-1.26 B	-1.23 B	-1.2 B	-1.17 B	-1.14 B	-1.12 B	-1.1 B	-1.09 B	-1.07 B	-1.07 B	-1.07 B	-1.07 B	-1.01 B	-1.01 B	-1.01 B	-1.01 B	-962 M	-962 M	-962 M	-962 M	-813 M	-813 M	-813 M	-813 M	-719 M	-719 M	-719 M	-719 M	-591 M	-591 M	-591 M	-591 M	-464 M	-464 M	-464 M	-464 M	-346 M	-346 M	-346 M	-346 M	-264 M	-264 M	-264 M	-264 M	-205 M	-205 M	-205 M	-205 M
Total Assets	823 M	846 M	869 M	466 M	280 M	299 M	325 M	353 M	369 M	403 M	424 M	445 M	460 M	205 M	219 M	236 M	236 M	236 M	236 M	123 M	123 M	123 M	123 M	156 M	156 M	156 M	156 M	316 M	316 M	316 M	316 M	383 M	383 M	383 M	383 M	338 M	338 M	338 M	338 M	248 M	248 M	248 M	248 M	347 M	347 M	347 M	347 M	126 M	126 M	126 M	126 M	98 M	98 M	98 M	98 M
Cash and Cash Equivalents	36.4 M	42.7 M	115 M	34.8 M	21.1 M	28.2 M	54.1 M	29.4 M	18.6 M	28.4 M	25.3 M	39.1 M	72.2 M	43.4 M	69.3 M	43.8 M	43.8 M	43.8 M	43.8 M	11.2 M	11.2 M	11.2 M	11.2 M	24.3 M	24.3 M	24.3 M	24.3 M	40.3 M	40.3 M	40.3 M	40.3 M	42.5 M	42.5 M	42.5 M	42.5 M	72.1 M	72.1 M	72.1 M	72.1 M	28 M	28 M	28 M	28 M	169 M	169 M	169 M	169 M	24.9 M	24.9 M	24.9 M	24.9 M	11.9 M	11.9 M	11.9 M	11.9 M
Book Value	786 M	814 M	839 M	429 M	247 M	278 M	303 M	326 M	345 M	365 M	398 M	419 M	437 M	182 M	194 M	209 M	209 M	209 M	209 M	94 M	94 M	94 M	94 M	124 M	124 M	124 M	124 M	236 M	236 M	236 M	236 M	265 M	265 M	265 M	265 M	290 M	290 M	290 M	290 M	212 M	212 M	212 M	212 M	320 M	320 M	320 M	320 M	95.8 M	95.8 M	95.8 M	95.8 M	68.7 M	68.7 M	68.7 M	68.7 M
Total Shareholders Equity	786 M	814 M	839 M	429 M	247 M	278 M	303 M	326 M	345 M	365 M	398 M	419 M	437 M	182 M	194 M	209 M	209 M	209 M	209 M	94 M	94 M	94 M	94 M	124 M	124 M	124 M	124 M	236 M	236 M	236 M	236 M	265 M	265 M	265 M	265 M	290 M	290 M	290 M	290 M	212 M	212 M	212 M	212 M	320 M	320 M	320 M	320 M	95.8 M	95.8 M	95.8 M	95.8 M	68.7 M	68.7 M	68.7 M	68.7 M

All numbers in USD currency